Jianing Guo
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Impact of pelvic lymph node dissection on survival outcomes in non-muscle invasive bladder cancer: a multicenter retrospective study.
Journal: Scientific reports
Published: January 04, 2025
The comparison of outcomes between neoadjuvant novel and classical hormonal therapy in patients with locally advanced prostate cancer: a retrospective study.
Journal: BMC urology
Published: November 10, 2024
Phase II Pilot Trial of Tislelizumab plus Low-Dose Nab-Paclitaxel for Extensive Very High-Risk Non-Muscle-Invasive Bladder Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 06, 2024
Analysis of Clinicopathological Characteristics and Factors Affecting the Prognosis of Patients With Resectable Sarcomatoid Carcinoma of the Bladder
Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
Published: April 21, 2024
Target deubiquitinase OTUB1 as a therapeatic strategy for BLCA via β-catenin/necroptosis signal pathway.
Journal: International journal of biological sciences
Published: January 07, 2024
TNIK drives castration-resistant prostate cancer via phosphorylating EGFR.
Journal: iScience
Published: August 01, 2023
HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer.
Journal: Cell death & disease
Published: August 14, 2022
BUB1 drives the occurrence and development of bladder cancer by mediating the STAT3 signaling pathway.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 20, 2021
Radical cystectomy for pT1 urothelial carcinoma of bladder not amenable to TURBT: Long-term results.
Radical cystectomy for pT1 urothelial carcinoma of bladder not amenable to TURBT: Long-term results.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: April 25, 2019
Pim-3 is a Critical Risk Factor in Development and Prognosis of Prostate Cancer.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: November 09, 2016
Last Updated: 09/26/2026